Population
Patients at risk of Asian influenza (H2N2)
Design
Review
Authors
Loading...
Historical limitations inform cautious antiviral selection today; leaves open questions on optimized prophylaxis development.
Amantadine was the first antiviral agent licensed in the US for influenza prophylaxis, though its early use was limited by side effects and diagnostic challenges.
R. Gordon Douglas (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: